05 February 1994 00:00 [Source: ICB]
RHÔNE-POULENC RORER Q1 sales declined 5% to $871m from $916m as lower demand for influenza products in France and government measures in Japan and Italy offset strong growth in the global Armour business and increased sales in Germany and the North American prescription business.
Net income fell 21.8% to $73.7m from $94.2m. Company president Robert Cawthorn said the group was 'reviewing a restructuring programme designed to reduce certain costs'. The cost of the programme 'is likely to be material to the 1994 results'.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|